Network-based method to infer the contributions of proteins to the etiology of drug side effects

Studying the molecular mechanisms that underlie the relationship between drugs and the side effects they produce is critical for drug discovery and drug development. Currently, however, computational methods are still unavailable to assess drug-protein interactions with the aim of globally inferring the contributions of various classes of proteins toward the etiology of side effects. In this work, we integrated data reflecting drug-side effect relationships, drugtarget relationships, and protein-protein interactions to develop a novel network-based probabilistic model, SidePro, to evaluate the contributions of proteins toward the etiology of side effects. For a given side effect, the method applies an expectation—maximization algorithm and a diffusion kernel-based approach to estimate each protein’s contribution. We applied this method to a wide range of side effects and validated the results using cross-validation and records from the Side Effect Resource database. We also studied a specific side effect, nephrotoxicity, which is known to be associated with the irrational use of the Chinese herbal compound triptolide, a diterpenoid epoxide in the Thunder of God Vine, Tripterygium wilfordii (Lei-Gong-Teng). Using triptolide as an example, we scored the target proteins of triptolide using our model and investigated the high-scoring proteins and their related biological processes. The results demonstrated that our model could differentiate between the potential side effect targets and therapeutic targets of triptolide. Overall, the proposed model could accurately pinpoint the molecular mechanisms of drug side effects, thus making contribution to safe and effective drug development.

[1]  Doheon Lee,et al.  Building the process-drug–side effect network to discover the relationship between biological Processes and side effects , 2011, BMC Bioinformatics.

[2]  L. Xiangjun,et al.  ? Higher Education Press and Springer-Verlag 2007 , 2007 .

[3]  Damian Szklarczyk,et al.  STITCH 3: zooming in on protein–chemical interactions , 2011, Nucleic Acids Res..

[4]  John D. Lafferty,et al.  Diffusion Kernels on Graphs and Other Discrete Input Spaces , 2002, ICML.

[5]  J. Chen,et al.  Predicting adverse drug reaction profiles by integrating protein interaction networks with drug structures , 2013, Proteomics.

[6]  Daniel C. Liebler,et al.  Elucidating mechanisms of drug-induced toxicity , 2005, Nature Reviews Drug Discovery.

[7]  R. Zatz,et al.  Cyclooxygenase-2 (COX-2) inhibition limits abnormal COX-2 expression and progressive injury in the remnant kidney. , 2003, Kidney international.

[8]  Bo Zhang,et al.  Network target for screening synergistic drug combinations with application to traditional Chinese medicine , 2011, BMC Systems Biology.

[9]  Chih-Jen Lin,et al.  Simple Probabilistic Predictions for Support Vector Regression , 2004 .

[10]  R. Sinniah,et al.  Downregulation of Bcl-2 by podocytes is associated with progressive glomerular injury and clinical indices of poor renal prognosis in human IgA nephropathy. , 2004, Journal of the American Society of Nephrology : JASN.

[11]  Jin Gu,et al.  Imbalanced network biomarkers for traditional Chinese medicine Syndrome in gastritis patients , 2013, Scientific Reports.

[12]  Shiwen Zhao,et al.  Network-Based Relating Pharmacological and Genomic Spaces for Drug Target Identification , 2010, PloS one.

[13]  Lan Fan,et al.  Pharmacogenetics of drugs withdrawn from the market. , 2012, Pharmacogenomics.

[14]  Allen D. Roses,et al.  Pharmacogenetics and drug development: the path to safer and more effective drugs , 2004, Nature Reviews Genetics.

[15]  Roded Sharan,et al.  An Algorithmic Framework for Predicting Side-Effects of Drugs , 2010, RECOMB.

[16]  R. Nowack,et al.  Herbal treatments of glomerulonephritis and chronic renal failure: Review and recommendations for research , 2011 .

[17]  Michael J. Keiser,et al.  Large Scale Prediction and Testing of Drug Activity on Side-Effect Targets , 2012, Nature.

[18]  M. Jadoul,et al.  Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs , 1993, The Lancet.

[19]  Livia Perfetto,et al.  MINT, the molecular interaction database: 2009 update , 2009, Nucleic Acids Res..

[20]  Bo Zhang,et al.  An Integrative Platform of TCM Network Pharmacology and Its Application on a Herbal Formula, Qing-Luo-Yin , 2013, Evidence-based complementary and alternative medicine : eCAM.

[21]  Navdeep Jaitly,et al.  A Structure-Based Approach for Mapping Adverse Drug Reactions to the Perturbation of Underlying Biological Pathways , 2010, PloS one.

[22]  Bin Chen,et al.  Gaining Insight into Off-Target Mediated Effects of Drug Candidates with a Comprehensive Systems Chemical Biology Analysis , 2009, J. Chem. Inf. Model..

[23]  P. Bork,et al.  Systematic identification of proteins that elicit drug side effects , 2013, Molecular systems biology.

[24]  Rafael C. Jimenez,et al.  The IntAct molecular interaction database in 2012 , 2011, Nucleic Acids Res..

[25]  Gary D Bader,et al.  BIND--The Biomolecular Interaction Network Database. , 2001, Nucleic acids research.

[26]  Chih-Jen Lin,et al.  LIBSVM: A library for support vector machines , 2011, TIST.

[27]  A. Hishida,et al.  Attenuation of cisplatin-induced acute renal failure is associated with less apoptotic cell death. , 1999, The Journal of laboratory and clinical medicine.

[28]  Hanno Steen,et al.  Development of human protein reference database as an initial platform for approaching systems biology in humans. , 2003, Genome research.

[29]  T. Efferth,et al.  Mechanisms of herb-induced nephrotoxicity. , 2013, Current medicinal chemistry.

[30]  Yoshihiro Yamanishi,et al.  Relating drug–protein interaction network with drug side effects , 2012, Bioinform..

[31]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[32]  Shao Li,et al.  A novel network pharmacology approach to analyse traditional herbal formulae: the Liu-Wei-Di-Huang pill as a case study. , 2014, Molecular bioSystems.

[33]  Yoshihiro Yamanishi,et al.  Drug Side-Effect Prediction Based on the Integration of Chemical and Biological Spaces , 2012, J. Chem. Inf. Model..

[34]  R. Harris,et al.  COX-2 and the Kidney , 2006, Journal of cardiovascular pharmacology.

[35]  David S. Wishart,et al.  DrugBank 3.0: a comprehensive resource for ‘Omics’ research on drugs , 2010, Nucleic Acids Res..

[36]  P. Bork,et al.  A side effect resource to capture phenotypic effects of drugs , 2010, Molecular systems biology.

[37]  J. Chen,et al.  Predicting adverse side effects of drugs , 2011, BMC Genomics.

[38]  H. Liapis,et al.  Expression of bcl-2 and bax in regenerating rat renal tubules following ischemic injury. , 1997, The American journal of physiology.

[39]  Bo Zhang,et al.  Herb network construction and co-module analysis for uncovering the combination rule of traditional Chinese herbal formulae , 2010, BMC Bioinform..

[40]  Igor Jurisica,et al.  Online Predicted Human Interaction Database , 2005, Bioinform..

[41]  Seth I. Berger,et al.  Role of systems pharmacology in understanding drug adverse events , 2011, Wiley interdisciplinary reviews. Systems biology and medicine.

[42]  M. Milik,et al.  Mapping adverse drug reactions in chemical space. , 2009, Journal of medicinal chemistry.

[43]  L. Hunyady,et al.  Identification of the invariant chain (CD74) as an angiotensin AGTR1-interacting protein. , 2008, The Journal of endocrinology.

[44]  James L Stevens,et al.  The future of drug safety testing: expanding the view and narrowing the focus. , 2009, Drug discovery today.

[45]  R. Shah,et al.  Can pharmacogenetics help rescue drugs withdrawn from the market? , 2006, Pharmacogenomics.